| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/26/2002 | WO2002075609A2 Predicting metabolic stability of drug molecules |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002075321A1 Array-based biomolecule analysis |
| 09/26/2002 | WO2002075320A2 Liver function test |
| 09/26/2002 | WO2002075319A1 Compositions for detecting skin-aging factor and detection method |
| 09/26/2002 | WO2002075318A2 Neurofibrillary labels |
| 09/26/2002 | WO2002075317A2 Screening for drugs against disorders associated with schizophrenia |
| 09/26/2002 | WO2002075316A2 Method of detecting amyloid-containing lesions by autofluorescence |
| 09/26/2002 | WO2002075315A1 Method of screening prediabetic state and screening reagent |
| 09/26/2002 | WO2002075313A1 A kit and method for detecting fecal parasites |
| 09/26/2002 | WO2002075312A1 Characterization of reaction variables |
| 09/26/2002 | WO2002075311A1 Multiplex protein interaction determinations using glutathione-gst binding |
| 09/26/2002 | WO2002075310A1 A method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
| 09/26/2002 | WO2002075309A1 Processes for producing coated magnetic microparticles and uses thereof |
| 09/26/2002 | WO2002075308A2 A kit and method for detecting food allergies |
| 09/26/2002 | WO2002075307A1 Method for sample identification in a mammal as well as a kit for performing this method |
| 09/26/2002 | WO2002075306A1 Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications |
| 09/26/2002 | WO2002075305A1 Quality testing method and production method of rare earth magnet alloy ingot, the rare earth magnet alloy ingot, and rare earth magnet alloy |
| 09/26/2002 | WO2002075304A1 Method of examining allergic disease |
| 09/26/2002 | WO2002075303A1 System and method for calibration and verification of a sample analysis instrument |
| 09/26/2002 | WO2002075301A2 Diagnosis of pathogen infections using mass spectral analysis of immune system modulators in post-exposure biological samples. |
| 09/26/2002 | WO2002075300A1 Method and measuring device for analysing the carbon dioxide content in water |
| 09/26/2002 | WO2002075299A1 Method for testing weld points using a robotic device comprising an ultrasonic test probe mounted on a robotic arm and a corresponding robotic device |
| 09/26/2002 | WO2002075293A1 Device and method for automatically producing a thermal recoil response in nematodes |
| 09/26/2002 | WO2002075289A2 Method and apparatus for improving the accuracy of noninvasive hematocrit measurements |
| 09/26/2002 | WO2002075288A1 Mid infra red analysis |
| 09/26/2002 | WO2002075281A1 Vacuum sensor |
| 09/26/2002 | WO2002075280A2 Examination device and method for examination of chemical and/or biological samples |
| 09/26/2002 | WO2002075278A2 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 09/26/2002 | WO2002075274A2 Method and kit for following neurodegenerative diseases |
| 09/26/2002 | WO2002075273A2 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor |
| 09/26/2002 | WO2002075257A2 Enhanced triaxial tester with volume change device for measurement of flow properties of dry particulate systems under low confining pressures |
| 09/26/2002 | WO2002074997A1 Fluorescent polymer superquenching-based bioassays |
| 09/26/2002 | WO2002074987A2 Quantitative diagnostic analysis of hypertonia |
| 09/26/2002 | WO2002074986A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | WO2002074985A2 Method of detecting macromolecular biopolymers by means of an electrode arrangement |
| 09/26/2002 | WO2002074984A2 Biosensor, device and method for detecting nucleic acids by means of at least two units for immobilizing nucleic acids |
| 09/26/2002 | WO2002074983A1 Sensor arrangement, device and method for testing active substances and/or active sites from a pharmacological point of view using an amperometer and/or potentiometer |
| 09/26/2002 | WO2002074982A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states |
| 09/26/2002 | WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | WO2002074979A2 Expression profiles and methods of use |
| 09/26/2002 | WO2002074976A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/26/2002 | WO2002074972A1 Method of assaying lupus anticoagulant and assay reagent |
| 09/26/2002 | WO2002074967A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 09/26/2002 | WO2002074950A1 Method of analyzing intermolecular interaction |
| 09/26/2002 | WO2002074937A1 Method of differentiating immature liver cells by using extracellular matrix |
| 09/26/2002 | WO2002074927A2 High accuracy protein identification |
| 09/26/2002 | WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 09/26/2002 | WO2002074923A2 Targets and screens for agents useful in controlling parasitic nematodes |
| 09/26/2002 | WO2002074921A2 Methods for isolating proteins expressed by dendritic cells |
| 09/26/2002 | WO2002074914A2 Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals |
| 09/26/2002 | WO2002074908A2 Methods and reagents for regulating apoptosis |
| 09/26/2002 | WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | WO2002074899A1 Enhancing surfaces for analyte detection |
| 09/26/2002 | WO2002074896A2 Method for analysing conditions in a container |
| 09/26/2002 | WO2002074810A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | WO2002074805A1 Soluble rage protein |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074797A2 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections |
| 09/26/2002 | WO2002074796A2 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | WO2002074793A2 Novel peptides for the diagnosis of schizophrenia |
| 09/26/2002 | WO2002074789A2 Use of monoclonal antibodies and functional assays for prediction of risk of opportunistic infection |
| 09/26/2002 | WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | WO2002074439A1 Analysing device for analysing chemical and/or biological samples |
| 09/26/2002 | WO2002074438A2 Structural units that define fluidic functions |
| 09/26/2002 | WO2002074434A2 Surface comprising a pattern of cells and method for production thereof |
| 09/26/2002 | WO2002074339A1 Deveice and method for the photodynamic diagnosis of tumor tissue |
| 09/26/2002 | WO2002074328A1 Methods of treating respiratory conditions |
| 09/26/2002 | WO2002074251A2 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074240A2 Anti-amyloid antibody based diagnosis and treatment of a neurological disease or disorder |
| 09/26/2002 | WO2002074171A1 Fluorescent cobalamins and uses thereof |
| 09/26/2002 | WO2002074077A1 Skin disease model mice, feed for constructing the same and method of evaluating test substance with the use of the mice |
| 09/26/2002 | WO2002074048A2 P-glycoproteins and uses thereof |
| 09/26/2002 | WO2002074043A2 Device for the examination of fluids |
| 09/26/2002 | WO2002074035A2 Method for generating a hierarchical topological tree of 2d or 3d-structural formulas of chemical compounds for property optimisation of chemical compounds |
| 09/26/2002 | WO2002066683A3 Optoelectronic detection system |
| 09/26/2002 | WO2002065094A3 Bottom plate for lysimeters and method for closing lysimeters with a bottom plate |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002062957A3 Ter sites and ter binding proteins |
| 09/26/2002 | WO2002061420A3 Vitro in a cell interaction culture system for testing and developing medicaments |
| 09/26/2002 | WO2002055991A3 Tandem mass spectrometry of prostaglandin isomers |
| 09/26/2002 | WO2002055665A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 09/26/2002 | WO2002055019A3 Methods for ameliorating childhood infections |
| 09/26/2002 | WO2002052919A3 Methods of searching for solid forms and screening a sample according to its forms |
| 09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/26/2002 | WO2002044721A9 Analytic method and reagent for use thereof |
| 09/26/2002 | WO2002042767A3 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 09/26/2002 | WO2002040501A3 Membrane scaffold proteins |
| 09/26/2002 | WO2002037108A8 Reagent and method for detecting substance |
| 09/26/2002 | WO2002035232A3 Method for detecting ovarian cancer based on human kallikrein 6 (hk6) |
| 09/26/2002 | WO2002026954A3 Truncated phosphodiesterase-7 polypeptides |
| 09/26/2002 | WO2002022685A3 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/26/2002 | WO2002018941A3 Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| 09/26/2002 | WO2002018634A3 Arrays of immobilised biomolecules, production and use thereof |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |